arrow
D

Dario de Biase

IRCCS Azienda Ospedaliero-Universitaria di Bologna
H指数:39
被引数:5,353

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detection of NTRK1/2/3 rearrangements in pigmented spindle cell naevus of Reed: a comparative study of optimized pan‐ TRK immunohistochemistry, FISH  and  RNA ‐ NGS

检测Reed色素梭形细胞痣中<i>NTRK1/2/3</i>重排:优化全<scp>TRK</scp>免疫组化、<scp>FISH</scp>和<scp>RNA</scp>-<scp>NGS</scp>的比较研究

2026-10-090
OAAI
OC1.6 - ECE_1657 - Percentage of mutated neoplastic cells predicts the risk of persistent/recurrent disease in a cohort of patients with BRAF-mutated papillary thyroid carcinoma

OC1.6 - ECE_1657 - 突变新生物细胞的百分比预测BRAF突变乳头状甲状腺癌患者队列中持续/复发性疾病的风险

2026-08-100
OAAI
Focus on the Interactive Cooperation Among Mechanotransduction and Biochemical Processes in Pancreatic Ductal Adenocarcinoma Development and Possible Adjuvant Role of Retinoic Acid for Its Treatment: A Narrative Review

聚焦于胰腺导管腺癌发展中机械转导与生化过程的交互合作及维甲酸可能的辅助治疗作用:一篇叙述性综述

Cancers
IF4.4
2026-06-150
OA
FGFR1 mutations identified in FOXL2-wild type ovarian adult granulosa cell tumors are not present in testicular counterparts: Re-analysis of a multi-institutional series

FGFR1基因突变在FOXL2野生型卵巢成人颗粒细胞瘤中被鉴定,而在睾丸对应组织中不存在:对多机构系列样本的再分析

2026-04-180
OAAI
Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus

将PIK3CA检测整合到晚期HR+/HER2-乳腺癌临床实践中的专家共识

2026-04-100
OAAI
Performance and clinical utility of two targeted multigene panels for GIST molecular characterization

两种靶向多基因panel在GIST分子特征分析中的性能与临床应用价值

2025-12-170
OAAI
Adult granulosa cell tumours of the testis analogous to ovarian counterparts are exceptionally rare: analysis of a multicentric series and review of the literature

睾丸成人型颗粒细胞瘤类似于卵巢对应肿瘤,极为罕见:多中心病例系列分析及文献综述

2025-11-010
OAAI
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study

一线免疫治疗联合或不联合化疗与BRAF联合MEK抑制剂在BRAFV600E突变型转移性非小细胞肺癌中的比较(FRONT-BRAF):一项多中心、回顾性队列研究

2025-09-290
PRE
Liquid biopsy in prostate cancer: A multidisciplinary expert consensus statement

液体活检在前列腺癌中的应用:多学科专家共识声明

2025-09-010
PRE
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype

子宫内膜癌与免疫逃逸:HLA I类分子丢失在NSMP亚型中的预后相关性

2025-08-120
OAAI
Therapeutic potential of lorlatinib in ALK-mutated metastatic paraganglioma: insights from clinical case report and literature review

洛拉替尼在ALK突变转移性副神经节瘤中的治疗潜力:临床病例报告和文献综述的见解

2025-08-070
OAAI
Corrigendum to “Exploring the role of TERT in thyroid cancer: A systematic review” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792]

勘误 “探究TERT在甲状腺癌中的作用:一项系统综述” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792]

2025-07-290
OA
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience

关于接受免疫为基础的联合治疗或靶向治疗的晚期肾细胞癌中3p染色体突变影响的见解:一项单中心经验

2025-06-010
PRE
Distinctive features of blood- and ascitic fluid-derived extracellular vesicles in ovarian cancer patients

卵巢癌患者血液和腹水来源的细胞外囊泡的独特特征

2025-04-210
OA